Principal Securities, Inc. Blueprint Medicines Corp Transaction History
Principal Securities, Inc.
- $4.14 Trillion
- Q3 2024
A detailed history of Principal Securities, Inc. transactions in Blueprint Medicines Corp stock. As of the latest transaction made, Principal Securities, Inc. holds 19 shares of BPMC stock, worth $1,712. This represents 0.0% of its overall portfolio holdings.
Number of Shares
19Holding current value
$1,712% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding BPMC
# of Institutions
351Shares Held
60.3MCall Options Held
2.25MPut Options Held
1.18M-
Vanguard Group Inc Valley Forge, PA6.68MShares$602 Million0.01% of portfolio
-
Black Rock Inc. New York, NY6.65MShares$599 Million0.02% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD5.39MShares$486 Million0.06% of portfolio
-
Wellington Management Group LLP Boston, MA3.96MShares$357 Million0.07% of portfolio
-
State Street Corp Boston, MA2.77MShares$249 Million0.01% of portfolio
About Blueprint Medicines Corp
- Ticker BPMC
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 59,719,600
- Market Cap $5.38B
- Description
- Blueprint Medicines Corporation, a precision therapy company, develops medicines for genomically defined cancers and blood disorders in the United States and internationally. The company is developing AYVAKIT for the treatment of systemic mastocytosis (SM) and gastrointestinal stromal tumors; BLU-263, an orally available, potent, and KIT inhibit...